You are here:
Two key factors set the Vaccine Alliance apart from other actors in the field of international health aid:
In this section, we explain Gavi’s unique business model and the six ways it delivers "added value".
Donor and developing countries need to see proof of the value of new vaccines before investing.
Immunisation is a commitment for life that requires guaranteed, long-term funding.
Developing countries decide for themselves how best to use Gavi support for immunisation.
It's not enough to buy new vaccines. They have to safely reach every child.
Manufacturers will only make vaccines for poor countries if they know they can sell them .
National immunisation programes must survive long after Gavi support stops.
70% of cervical cancer cases can be prevented with human papillomavirus vaccines. One woman dies from cervical cancer every two minutes - or 275,000 a year - over 85% in the developing world.
24 March 2015
Be Bold: How Gavi Will Immunise Another 300 Million Children
18 March 2015
How to Fight the Next Epidemic
The New York Times
Share the risks of Ebola vaccine development
06 March 2015
Bill Gates: Why I'm betting on the Gulf to help fight extreme poverty and disease
19 February 2015
27 January 2015
Donors pledge record $7.5B for global vaccines program
The Daily Mail
22 January 2015
A Birthday Gift to Last a Lifetime
The Huffington Post
11 January 2015
The United States should generously support Gavi's immunization efforts
The Washington Post
06 January 2015
Gates Foundation Uses Art to Encourage Vaccination
18 December 2014
A global conspiracy of health
Concerned about the misuse of Gavi resources? Report it now.
© Gavi 2015
modal window here